Articles
| Open Access |
https://doi.org/10.55640/
THE ROLE OF NEOADJUVANT CHEMORADIATION THERAPY IN THE TREATMENT OF ESOPHAGEAL CANCER
Makhsudov Bekhruzbek Dilshodbek ugli , 1st year master of Tashkent Medical AcademyAbstract
Currently, the choice of treatment method for patients with stage II-III esophageal cancer using neoadjuvant chemoradiation therapy is considered justified. This paper presents the results of evaluating the effectiveness of treating locally advanced esophageal cancer using independent remote radiation therapy, as well as competitive chemoradiation therapy.
Keywords
Esophageal cancer, locally advanced process, chemoradiation therapy.
References
The state of oncological care for the population of Russia in 2021. Ed. by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. M. 2022; 239 p.
Tryakin A.A., Besova N.S., Volkov N.M., Gamayunov S.V., Kononets P.V., Levchenko E.V. et al. Practical recommendations for drug treatment of cancer of the esophagus and esophagogastric junction. Malignant tumors: Practical recommendations RUSSCO, 2022; (v. 12): 366-381. DOI: 10.18027/2224-5057-2022-12-3s2-366-381
Results of the oncology service of the Saratov region in 2021. MZ SO GUZ "Regional Clinical Oncology Dispensary". Saratov, 2022. 35 p.
Torre L.A., Bray F., Siegel R.L. et al. Global cancer statistics 2012. CA Cancer J. Clin. 2015; 65(2):87-108. DOI:10.3322/caac.21262
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.